Pharma

Laborie to Acquire JADA System from Organon for Up to $465 Million

FDA Approves Bayer’s Lynkuet as First Dual-Target Non-Hormonal Treatment for Menopause Hot Flashes

Hope Medicine Completes Phase 2 Trial of Non-Hormonal Endometriosis Treatment

FDA Approves New Generic Abortion Pill from Evita Solutions

FDA Approves Henlius-Organon Denosumab Biosimilars for Osteoporosis and Bone Cancer Treatment

Reunion Neuroscience Reports Positive Phase 2 Results for Psychedelic Postpartum Depression Treatment

AbbVie Receives UK MHRA Approval for Ovarian Cancer Treatment ELAHERE

Daré Bioscience Reports Positive Contraception Trial Results as Smart Drug Delivery Platform Shows Broader Potential

Bayer Receives First Global Approval for Lynkuet to Treat Menopause Vasomotor Symptoms

Organon Discontinues Endometriosis Drug Development After Failed Phase 2 Trial

The Organization That Made History: How Medicines360’s New Innovation Hub Is Scaling Access-First Women’s Health Solutions

Merck’s Immunotherapy Shows Survival Benefit in Platinum-Resistant Ovarian Cancer Trial

Gedeon Richter Takes ‘Significant Equity Stake’ in Fertility Company Granata Bio

Organon Acquires Arthritis Biosimilar from Biogen

FDA Approves First New UTI Antibiotic Class in 30 Years

Health In Her HUE Partners with Takeda to Increase Black Women’s Access to Clinical Trials

Cosette Pharmaceuticals to Acquire Mayne Pharma for $430M; Accelerating Impact in Women’s Health and Dermatology

Daré Bioscience and Theramex Partner to Develop Biodegradable Contraceptive Implant

Roche Receives FDA Clearance for Rapid STI Tests at Point of Care

Gesynta Pharma Raises $29M to Advance Non-Hormonal Endometriosis Treatment

Bayer’s Elinzanetant Shows Positive Results for Treatment of Hot Flashes in Breast Cancer Patients

Novartis Reports Extended Efficacy of Kisqali in Early Breast Cancer Treatment

Merck Announces Positive Results for Ovarian Cancer Treatment Trial

AbbVie’s ELAHERE Receives EU Approval for Treating Platinum-Resistant Ovarian Cancer